PRP Acquires Interest in AmerisourceBergen’s 429,122 SF Metro Philadelphia Headquarters Building

CONSHOHOCKEN, PA. — Washington, D.C.-based investment firm PRP has acquired a preferred equity investment in the 429,122-square-foot office headquarters building of drug wholesaler AmerisourceBergen in Conshohocken, a northern suburb of Philadelphia. The Philadelphia Business Journal reports that the value of PRP’s stake is $340 million. Developer Keystone Property Group is nearing completion of the headquarters building, which will be located within the company’s $325 million SORA West mixed-use development and will house approximately 1,500 AmerisourceBergen associates. The company announced its plan to relocate to Conshohocken from Chesterbrook in summer 2018.